{"id":"W4400109243","doi":"10.1200/jco.2024.42.16_suppl.7007","title":"Efficacy and safety of ibrutinib plus venetoclax in patients with mantle cell lymphoma (MCL) and <i>TP53</i> mutations in the SYMPATICO study.","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"ca_institutions":"Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Medicine; Ven; Venetoclax; Ibrutinib; Mantle cell lymphoma; Internal medicine; Hazard ratio; Population; Phases of clinical research; Bendamustine; Neutropenia; Gastroenterology; Oncology; Rituximab; Toxicity; Lymphoma; Confidence interval; Leukemia; Chronic lymphocytic leukemia","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003117236,0.0001053729,0.000843549,0.0001872334,0.000022597,0.00001414414,0.0001341167,0.0001552952,0.00001604655],"category_scores_gemma":[0.001166612,0.00005876751,0.00006881876,0.0003108627,0.0003062434,0.00007260517,0.00007219536,0.0005414155,0.000002773218],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002051936,"about_ca_system_score_gemma":0.01004796,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001075658,"about_ca_topic_score_gemma":0.0001277885,"domain_scores_codex":[0.997072,0.0005490341,0.00152183,0.000185508,0.0004741791,0.0001973902],"domain_scores_gemma":[0.9934097,0.005806589,0.0003538608,0.0001693234,0.0001373727,0.0001231699],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0440552,0.01401469,0.6094974,0.0008185051,0.0006616743,0.005454222,0.01237202,0.0006474827,0.00003033913,0.0002232222,0.0008235459,0.3114017],"study_design_scores_gemma":[0.1174584,0.01812173,0.8580213,0.0003885233,0.0002435548,0.000209667,0.0009099867,0.002344113,0.000009024277,0.0001012204,0.002122856,0.00006963853],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9965804,0.0008789588,0.000009608366,0.0008015597,0.0001453301,0.0006738392,0.000003304928,0.000002940146,0.000904106],"genre_scores_gemma":[0.9991581,0.0002550383,0.0002152859,0.0002205753,0.0000906868,0.000005775743,0.000002128549,0.00001272939,0.00003962417],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.311332,"threshold_uncertainty_score":0.9955642,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04951817572860148,"score_gpt":0.4189142326057971,"score_spread":0.3693960568771957,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}